China Universal Asset Management Company’s Caribou Biosciences CRBU Stock Holding History

China Universal Asset Management Company’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.8K	Sell	15,785 -802	-5%	-$1.58K	﹤0.01%	488
2026 Q1	$31.5K	Buy	16,587 +1,356	+9%	+$2.33K	﹤0.01%	479
2025 Q4	$24.2K	Buy	+15,231	New	+$32K	﹤0.01%	483
2024 Q4	–	Sell	-17,380	Closed	-$34.1K	–	505
2024 Q3	$34.1K	Buy	17,380 +6,768	+64%	+$13.9K	﹤0.01%	398
2024 Q2	$17.4K	Sell	10,612 -6,412	-38%	-$20.5K	﹤0.01%	395
2024 Q1	$87.5K	Buy	17,024 +6,798	+66%	+$41.9K	0.01%	384
2023 Q4	$58.6K	Buy	10,226 +7,968	+353%	+$39.4K	0.01%	352
2023 Q3	$10.8K	Buy	2,258 +1,453	+180%	+$9.01K	﹤0.01%	341
2023 Q2	$3.42K	Sell	805 -22	-3%	-$99	﹤0.01%	401
2023 Q1	$4.39K	Buy	827 +207	+33%	+$1.29K	﹤0.01%	381
2022 Q4	$3.89K	Buy	620 +50	+9%	+$445	﹤0.01%	324
2022 Q3	$6K	Buy	+570	New	+$5.31K	﹤0.01%	247

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAA

Green Alpha Advisors Niwot, Colorado $149M AUM 118.1% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MAM

Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

China Universal Asset Management Company's CRBU Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Caribou Biosciences (CRBU) stake by 4.8% in Q2 2026, selling an estimated $1.58K and leaving 15,785 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

China Universal Asset Management Company first reported a position in CRBU in Q3 2022 and has held it in 12 quarters since. The position peaked at $87.5K in Q1 2024. 69 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

China Universal Asset Management Company held 15,785 shares of Caribou Biosciences worth $27.8K as of Q2 2026.
China Universal Asset Management Company sold 802 Caribou Biosciences shares in Q2 2026, an estimated $1.58K.
Caribou Biosciences made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #488 holding.
China Universal Asset Management Company first reported a position in Caribou Biosciences in Q3 2022 and has held it in 12 quarters since.
China Universal Asset Management Company's Caribou Biosciences position peaked at $87.5K in Q1 2024.
69 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.